NASDAQ:NRIX | Income Statement | Nurix Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-02-28 to 2026-05-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-05-31$9.04M$87.65M$103.25M-$94.2M-$89.81M-$271,000.00-$89.54M-$0.81-$0.81111,084,423111,084,423
2026-02-28$6.25M$84.14M$98.75M-$92.5M$0.00-$87.17M-$0.79-$0.79110,071,668110,071,668
2025-11-30$13.58M$83.02M$96.67M-$83.1M-$78.22M$0.00-$78.22M-$0.83-$0.832,797,4382,797,438
2025-08-31$7.89M$86.12M$99.28M-$91.39M-$86.42M$0.00-$86.42M-$1.03-$1.0384,159,33684,159,336
2025-05-31$44.06M$78.1M$92.38M-$48.32M-$42.7M$760,000.00-$43.46M-$0.52-$0.5283,882,47783,882,477
2025-02-28$18.45M$69.66M$81.32M-$62.86M-$56.35M$0.00-$56.35M-$0.67-$0.6783,560,79583,560,795
2024-11-30$13.28M$67.22M$77.94M-$64.66M-$58.54M$8,000.00-$58.55M-$0.75-$0.753,736,0923,736,092
2024-08-31$12.59M$55.48M$67.2M-$54.61M-$48.87M$82,000.00-$48.96M-$0.67-$0.6772,779,38172,779,381
2024-05-31$12.09M$48.92M$60.63M-$48.54M-$44.46M$90,000.00-$44.55M-$0.71-$0.7162,377,55162,377,551
2024-02-29$16.59M$50.01M$61.8M-$45.22M-$41.43M$90,000.00-$41.52M-$0.76-$0.7654,903,40754,903,407
2023-11-30$15.16M$49.71M$60.49M-$45.33M-$41.96M$0.00-$41.96M-$0.77-$0.77110,410110,410
2023-08-31$18.47M$47.86M$58.48M-$40.01M-$36.98M$0.00-$36.98M-$0.68-$0.6854,390,85954,390,859
2023-05-31$30.68M$45.76M$57.44M-$26.77M-$24.28M$0.00-$24.28M-$0.45-$0.4554,259,04554,259,045
2023-02-28$12.69M$45.82M$55.64M-$42.95M-$40.73M$0.00-$40.73M-$0.75-$0.7554,028,23854,028,238
2022-11-30$6.78M$46.11M$55.47M-$48.69M-$46.72M$0.00-$46.72M-$0.86-$0.861,772,2141,772,214
2022-08-31$10.79M$47.76M$57.51M-$46.72M-$45.71M$0.00-$45.71M-$0.90-$0.9050,868,54250,868,542
2022-05-31$11.43M$47.49M$57.15M-$45.72M-$45.4M$0.00-$45.4M-$1.01-$1.0144,898,40944,898,409
2022-02-28$9.62M$43.14M$52.37M-$42.74M-$42.53M$0.00-$42.53M-$0.95-$0.9544,693,81244,693,812
2021-11-30$7.4M$36.53M$45.35M-$37.95M-$37.66M$44,000.00-$37.7M-$0.85-$0.85550,963550,963
2021-08-31$10.25M$30.91M$39.25M-$29M-$28.96M-$123,000.00-$28.84M-$0.65-$0.6544,374,38944,374,389
2021-05-31$7.09M$25.99M$33.51M-$26.41M-$26.24M$139,000.00-$26.38M-$0.60-$0.6043,804,06643,804,066
2021-02-28$5.01M$23M$29.53M-$24.52M-$24.2M$71,000.00-$24.28M38,777,258
2020-11-30$6.69M$20.45M$26.7M-$20.01M-$19.87M$41,000.00-$19.91M7,620,519
2020-08-31$4.09M$18.94M$23.28M-$19.19M-$18.52M$0.00-$18.52M-$1.09-$1.0916,937,93416,937,934
2020-05-31$4.18M$14.14M$17.41M-$13.23M-$13.01M-$20.59M$7.58M$0.00$0.003,731,8384,909,829
2020-02-29$2.86M$12.97M$15.42M-$12.55M-$12.38M$11,000.00-$12.39M3,539,390
2019-11-30$12.82M$15.43M-$13.56M-$13.31M$210,000.00-$13.52M-141,295
2019-08-31$11.01M$13.19M-$2.61M-$2.42M$10,000.00-$2.43M3,667,335
2019-05-31-$3.07M
2019-02-28-$2.69M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-11-30$83.98M$316.9M$369.65M-$285.67M-$263.7M$760,000.00-$264.46M-$3.05-$3.0586,666,90786,666,907
2024-11-30$54.55M$221.63M$267.58M-$213.03M-$193.3M$270,000.00-$193.57M-$2.88-$2.8867,120,26667,120,266
2023-11-30$76.99M$189.15M$232.05M-$155.06M-$143.95M$0.00-$143.95M-$2.65-$2.6554,337,90154,337,901
2022-11-30$38.63M$184.5M$222.49M-$183.87M-$180.36M$0.00-$180.36M-$3.71-$3.7148,607,99048,607,990
2021-11-30$29.75M$116.43M$147.64M-$117.89M-$117.06M$131,000.00-$117.19M-$2.73-$2.7342,895,38342,895,383
2020-11-30$17.82M$66.49M$82.8M-$64.98M-$63.78M-$20.54M-$43.24M15,673,424
2019-11-30$31.12M$45.03M$53.35M-$22.24M-$21.46M$239,000.00-$21.7M3,292,514